SPECTRAL: An Intelligent and Ultra‐Sensitive Photonic Hydrogel Platform for Biomarker‐Based Cancer Prediction
- 13 May 2026
- journal article
- Published by Wiley in Angewandte Chemie
- Vol. 138 (27)
Abstract
Point‐of‐care (POC) biosensing holds great promise for noninvasive cancer diagnostics, as circulating tumor DNA (ctDNA) serves as a minimally invasive biomarker for early detection. However, effective ctDNA detection remains challenging due to low abundance and complex workflows. Herein, we present SPECTRAL (Smart Photonic‐hydrogel Enhanced chip for Cancer Type Recognition and AnaLysis), a sequencing‐free platform integrating photonic‐crystal hydrogels with charge‐neutral peptide nucleic acid (PNA) probes for efficient volumetric signal transduction and single‐nucleotide discrimination. Photonic‐crystal‐enhanced fluorescence amplifies signals of fluorescently labeled recombinase polymerase amplification (RPA) amplicons, achieving a detection limit of 100 copies per µL, with substantially improved sensitivity over conventional fluorescence assays. A single SPECTRAL chip simultaneously profiles 205 ctDNA mutations and eight protein biomarkers from plasma samples. The PNA sensor library is generated via an automated synthesis system guided by machine learning (ML)‐predicted probe difficulty. Multimodal signals are analyzed using cloud‐based ML to classify multiple cancer types (lung, breast, and colorectal), achieving 90.0% specificity and 86.7% sensitivity (87.5% overall accuracy) within 100 min from sample to diagnosis, based on validation with patient plasma samples. By combining molecular biosensing, photonic signal amplification, and AI‐driven analysis, SPECTRAL provides a low‐instrument‐dependent platform for decentralized liquid‐biopsy cancer diagnostics.Keywords
Funding Information
- National Medical Research Council (23‐0740‐A0001)
- National Natural Science Foundation of China (22208290)
- National Natural Science Foundation of China (22404153)
- China Postdoctoral Science Foundation (2025M771078)
- China Postdoctoral Science Foundation (2024M753044)
- China Postdoctoral Science Foundation (GZB20240693)
- Natural Science Foundation of Qingdao Municipality (24‐4‐4‐zrjj‐9‐jch)
This publication has 24 references indexed in Scilit:
- Automated high-purity fast-flow synthesis of cyclic peptide-PNA conjugates for drug discovery and nanotechnologyChemical Engineering Journal, 2025
- Label-free multiplexed detection based on core–shell photonic barcodes integrated RCABiosensors and Bioelectronics, 2024
- An Efficient CRISPR/Cas Cooperative Shearing Platform for Clinical Diagnostics ApplicationsAngewandte Chemie, 2024
- Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer ScreeningJAMA, 2024
- Applications of Liquid Biopsy for Surgical Patients With CancerJAMA Surgery, 2024
- Multiplex Identification of Post‐Translational Modifications at Point‐of‐Care by Deep Learning‐Assisted Hydrogel SensorsAngewandte Chemie, 2023
- Machine Learning Guides Peptide Nucleic Acid Flow Synthesis and Sequence DesignAdvanced Science, 2022
- Plasmonic Fluorescence Enhancement in Diagnostics for Clinical Tests at Point‐of‐Care: A Review of Recent TechnologiesAdvanced Materials, 2022
- Evolution of Hybridization Probes to DNA Machines and RobotsAccounts of Chemical Research, 2019
- Ultrasensitive DNA Detection Using Photonic CrystalsAngewandte Chemie, 2008